Meet the AmerisourceBergen Board of Directors

As one of the largest pharmaceutical companies in the world, AmerisourceBergen is overseen by a board of directors responsible for guiding the company's strategic direction. Let's take a closer look at who serves on the AmerisourceBergen Board of Directors, what their responsibilities are, and how they impact the company's operations.

Who are the members of the AmerisourceBergen Board of Directors?

The AmerisourceBergen Board of Directors is comprised of experienced leaders from various industries, including healthcare, technology, finance, and retail. The current members of the board are:

• Scott S. Hartz - Chairman of the Board
• Steven H. Collis - Chairman, President, and CEO of AmerisourceBergen
• Kathryn M. JohnBull - Retired Executive Vice President and CFO of ConocoPhillips
• Richard W. Gochnauer - Retired CEO of United Stationers and Chairman of World Business Chicago
• D. Mark Durcan - Retired CEO of Micron Technology
• Lon R. Greenberg - Retired Chairman and CEO of UGI Corporation
• Edward E. Hagenlocker - Retired Senior Partner of Goldman Sachs & Co.
• Henry W. McGee - EVP of HBO's Programming Group at Time Warner Inc.
• Orlando Ashford - President of Holland America Line
• Bridgette P. Heller - CEO of Caris Life Sciences
• Ellen R. Tauscher - Former Congresswoman and Under Secretary of State for Arms Control and International Security Affairs

Each member of the AmerisourceBergen Board of Directors brings a unique set of skills and experiences to the table. For example, Kathryn M. JohnBull has over 30 years of experience in finance and accounting, while Orlando Ashford has extensive experience in the travel and hospitality industry. The board's diverse backgrounds and expertise allow them to make informed decisions that benefit the company and its stakeholders.

The role and responsibilities of the AmerisourceBergen Board of Directors

The AmerisourceBergen Board of Directors is responsible for overseeing management and setting the company's strategic direction. The board's duties include:

• Establishing overall corporate strategy and overseeing major acquisitions and divestitures
• Ensuring compliance with legal and regulatory requirements
• Reviewing and approving the company's financial statements and budget
• Hiring, evaluating, and compensating the CEO and other members of senior management
• Approving executive compensation and benefits
• Ensuring the management team is developing and executing effective risk management strategies

In addition to these responsibilities, the AmerisourceBergen Board of Directors also plays a crucial role in maintaining the company's reputation and upholding its values. The board is responsible for ensuring that the company operates ethically and with integrity, and that it is committed to social responsibility and sustainability.

Furthermore, the board is responsible for ensuring that the company is adapting to changes in the market and industry trends. This includes staying up-to-date with emerging technologies and innovations, and making strategic decisions to keep the company competitive and relevant in the marketplace.

The history and evolution of the AmerisourceBergen Board of Directors

The AmerisourceBergen Board of Directors has a long history dating back to the company's founding in 2001. Over the years, the board has evolved to reflect changes in the company's leadership, industry trends, and governance best practices. Today's board is diverse, with members bringing a broad range of skills and knowledge to the table.

In 2018, the AmerisourceBergen Board of Directors made a significant change by appointing a new independent chairman. This move was made in response to shareholder concerns about the company's opioid-related legal issues and the need for stronger oversight. The new chairman brought extensive experience in healthcare and corporate governance, and has since led the board in implementing new policies and procedures to address these concerns.

What qualifications and experience do the AmerisourceBergen Board of Directors bring to their positions?

Members of the AmerisourceBergen Board of Directors bring a wealth of experience and knowledge gained from their careers in various industries. Collectively, the board members have expertise in finance, healthcare, law, management, marketing, technology, and more. In addition, each member undergoes a rigorous selection process that emphasizes professional and personal qualifications, as well as a commitment to corporate governance.

One of the key qualifications that the AmerisourceBergen Board of Directors possess is their extensive experience in the healthcare industry. Many of the board members have held senior leadership positions in healthcare companies, which gives them a deep understanding of the industry's complexities and challenges. This experience enables them to provide valuable insights and guidance to the company's management team.

Another important qualification that the board members bring to their positions is their global perspective. AmerisourceBergen operates in multiple countries, and the board members' diverse backgrounds and experiences enable them to understand the cultural and regulatory differences that exist in different regions. This knowledge helps the company to navigate complex international markets and make informed decisions that benefit the business and its stakeholders.

How does the AmerisourceBergen Board of Directors make decisions?

The AmerisourceBergen Board of Directors operates by a set of established bylaws and corporate governance guidelines that emphasize ethical conduct, responsible decision-making, and transparency. The board meets regularly to discuss and vote on key company matters, and decisions are made by a majority vote. Additionally, the board may form committees to address specific issues such as compensation, audit, and nominating.

Furthermore, the AmerisourceBergen Board of Directors also takes into consideration the opinions and feedback of the company's shareholders. Shareholders are given the opportunity to vote on important matters such as the election of board members and major corporate decisions. The board values the input of its shareholders and strives to make decisions that align with the best interests of the company and its stakeholders.

The relationship between the AmerisourceBergen Board of Directors and executive leadership

The AmerisourceBergen Board of Directors works closely with the CEO and other members of senior management to execute on the company's strategic plans. However, the board provides independent oversight and evaluation of management's performance. This separation of powers provides a checks-and-balances system that helps to ensure the company is operating in the best interests of shareholders and other stakeholders.

One way in which the AmerisourceBergen Board of Directors maintains its independence is through the use of committees. The board has several committees, including an audit committee, a compensation committee, and a nominating and governance committee. These committees are made up of independent directors who are responsible for overseeing specific areas of the company's operations.

In addition to its oversight role, the AmerisourceBergen Board of Directors also plays an important role in setting the company's strategic direction. The board works with executive leadership to identify key growth opportunities and to develop plans to capitalize on them. This collaborative approach helps to ensure that the company is well-positioned to succeed in a rapidly changing healthcare landscape.

The impact of the AmerisourceBergen Board of Directors on the company's strategic direction

The AmerisourceBergen Board of Directors is critical to shaping the strategic direction of the company. Through its oversight responsibilities and regular meetings with management, the board helps to identify key opportunities and challenges facing the company. By working collaboratively with management, the board strives to optimize AmerisourceBergen's performance and value for all stakeholders.

One of the key roles of the AmerisourceBergen Board of Directors is to ensure that the company operates in a socially responsible manner. This includes promoting ethical business practices, minimizing environmental impact, and supporting the communities in which AmerisourceBergen operates. By prioritizing these values, the board helps to build a strong reputation for the company and maintain the trust of its stakeholders.

The diversity and inclusivity initiatives within the AmerisourceBergen Board of Directors

AmerisourceBergen is committed to fostering a culture of diversity and inclusion, and that includes its board of directors. The company has implemented a range of initiatives to promote diversity at all levels of the organization, including on the board. AmerisourceBergen believes that a diverse board can bring unique perspectives and capabilities that can enhance the company's performance and value for shareholders.

One of the initiatives implemented by AmerisourceBergen to promote diversity on its board is the Board Diversity Policy. This policy outlines the company's commitment to diversity and sets specific goals for increasing the representation of women and minorities on the board. The policy also requires the board to consider diversity when nominating new members and to report on its progress towards achieving its diversity goals.

Comparing the AmerisourceBergen Board of Directors to other companies in the industry

The AmerisourceBergen Board of Directors compares favorably to other companies in the pharmaceutical and healthcare industries. The board is diverse, with a mix of industry experts and leaders from other sectors. Additionally, the board's extensive experience in various areas of business and governance has helped to guide the company through periods of growth and market volatility.

One area where the AmerisourceBergen Board of Directors stands out is in their commitment to corporate social responsibility. The board has implemented various initiatives to reduce the company's environmental impact and promote ethical business practices. This includes investing in renewable energy sources and partnering with organizations that promote sustainability.

Furthermore, the AmerisourceBergen Board of Directors has a strong track record of promoting diversity and inclusion within the company. The board has implemented policies to ensure that all employees have equal opportunities for advancement and that the company's workforce reflects the diversity of the communities it serves. This commitment to diversity has helped to create a more inclusive and innovative workplace culture at AmerisourceBergen.

Recent changes or additions to the AmerisourceBergen Board of Directors

One recent addition to the AmerisourceBergen Board of Directors is Orlando Ashford, who joined the board in 2018. Ashford is the President of Holland America Line and brings extensive experience in travel and leisure industries to the board. His addition is a reflection of AmerisourceBergen's commitment to attracting diverse and accomplished leaders to its board.

In addition to Orlando Ashford, AmerisourceBergen also recently appointed Dr. Lonnie Moulder to its Board of Directors. Dr. Moulder is the co-founder and CEO of Tizona Therapeutics, a biotechnology company focused on developing immunotherapies for cancer treatment. With his extensive experience in the healthcare industry, Dr. Moulder brings valuable insights to the board as AmerisourceBergen continues to expand its presence in the pharmaceutical sector.

Furthermore, AmerisourceBergen announced in its latest annual report that it has implemented a new board refreshment policy, which aims to ensure that the board is composed of directors with diverse backgrounds, skills, and experiences. The policy includes a mandatory retirement age of 75 for directors, as well as a commitment to regularly evaluate the board's composition and identify potential candidates for future appointments. This policy demonstrates AmerisourceBergen's dedication to maintaining a strong and effective board that can guide the company through the challenges and opportunities of the rapidly evolving healthcare industry.

Interviews with members of the AmerisourceBergen Board of Directors on their experiences and perspectives

AmerisourceBergen board members have shared their thoughts and insights on the company's governance, strategy, and performance in a variety of forums. In interviews and public statements, board members have emphasized the importance of ethical conduct, stakeholder engagement, and independent oversight. They have also discussed the challenges and opportunities facing the company in a rapidly changing healthcare landscape.

One of the key themes that emerged from the interviews with AmerisourceBergen board members was the company's commitment to innovation and technology. Board members highlighted the importance of leveraging data analytics, artificial intelligence, and other cutting-edge technologies to improve patient outcomes and drive business growth. They also discussed the need to stay ahead of regulatory changes and industry trends, and to continuously adapt and evolve in response to new challenges and opportunities.

The future outlook for the AmerisourceBergen Board of Directors and its role in shaping the company's future

The AmerisourceBergen Board of Directors plays a critical role in shaping the future of the company. Through its oversight responsibilities and collaboration with management, the board will continue to guide the company through challenges and opportunities in the healthcare industry. With its diverse mix of expertise and experience, the board is well-equipped to navigate the complexities of the pharmaceutical distribution market and ensure that AmerisourceBergen remains a leader in the industry.

One of the key areas of focus for the AmerisourceBergen Board of Directors in the coming years will be the company's digital transformation. As the healthcare industry increasingly relies on technology and data analytics, the board will need to ensure that AmerisourceBergen is keeping pace with these changes. This may involve investing in new technologies, hiring additional IT talent, and developing new partnerships with tech companies.

Another important area of focus for the board will be sustainability and corporate social responsibility. As consumers and investors become more conscious of the environmental and social impact of the companies they support, the board will need to ensure that AmerisourceBergen is taking steps to reduce its carbon footprint, promote diversity and inclusion, and give back to the communities it serves. This may involve setting new sustainability goals, partnering with non-profit organizations, and engaging with stakeholders to understand their concerns and priorities.

1. Who are the members of the AmerisourceBergen Board of Directors?
2. Scott S. Hartz
3. Steven H. Collis
5. Kathryn M. JohnBull
7. Richard W. Gochnauer
9. D. Mark Durcan
11. Lon R. Greenberg
13. Edward E. Hagenlocker
15. Henry W. McGee
17. Orlando Ashford
19. Bridgette P. Heller
21. Ellen R. Tauscher
24. What are the responsibilities of the AmerisourceBergen Board of Directors?
25. Establishing overall corporate strategy
26. Ensuring compliance with legal and regulatory requirements
28. Reviewing and approving financial statements and budgets
30. Hiring and evaluating senior management
32. Approving executive compensation and benefits
34. Ensuring effective risk management strategies
37. How does the AmerisourceBergen Board of Directors make decisions?
38. Operating by established bylaws and corporate governance guidelines
39. Emphasizing ethical conduct, responsible decision-making, and transparency
41. Meeting regularly to discuss and vote on key company matters
43. Making decisions by a majority vote
46. What qualifications and experience do the AmerisourceBergen Board of Directors bring to their positions?
47. Expertise in finance, healthcare, law, management, marketing, technology, and more
48. Careers in various industries
51. How does the AmerisourceBergen Board of Directors impact the company's strategic direction?
52. Guiding the company through challenges and opportunities in the healthcare industry
53. Ensuring that AmerisourceBergen remains a leader in the industry
55. Playing a critical role in shaping the company's future